Home › Former Biogen exec to lead Newton biotech, Chiasma
 

Keywords :   


Former Biogen exec to lead Newton biotech, Chiasma

2015-03-16 21:21:07| Biotech - Topix.net

A longtime pharmaceutical executive who oversaw the launch of Biogen Idec's first multiple sclerosis drug, Avonex, has been named CEO of a privately held Newton biotech. Chiasma Inc., which recently raised $70 million in Series E financing and last week told the Boston Business Journal that it's in the process of looking for a new, larger headquarters in either Newton or Cambridge, today named Mark Leuchtenberger as its president and CEO.

Tags: lead newton biotech exec

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.07Tropical Storm Beryl Graphics
05.07Atlantic Tropical Weather Outlook
05.07Tropical Storm Beryl Public Advisory Number 28A
05.07Summary for Tropical Storm Beryl (AT2/AL022024)
05.07Still no sign of herd rebuilding
05.07Eastern North Pacific Tropical Weather Outlook
05.07Tubi and Pluto lead U.S. surge in free streaming
05.07Tubi free streaming service launches in the UK
More »